Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN

Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN

Peroxisome proliferator-activated receptor gamma (PPARγ) agonist has anti-inflammatory and anticancer properties. However, the mechanisms by which PPARγ agonist rosiglitazone interferes with inflammation and cancer via phosphatase and tensin homolog-(PTEN)-dependent pathway remain unclear. We found...

Full description

Bibliographic Details
Main Authors: Chiou-Feng Lin, Kung-Chia Young, Chyi-Huey Bai, Bu-Chin Yu, Ching-Ting Ma, Yu-Chieh Chien, Chiu-Ling Chiang, Chao-Sheng Liao, Hsin-Wen Lai, Chiung-Wen Tsao
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/787924

Internet

http://dx.doi.org/10.1155/2014/787924

Similar Items